31 related articles for article (PubMed ID: 29222833)
1. Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial.
Ost P; Reynders D; Decaestecker K; Fonteyne V; Lumen N; De Bruycker A; Lambert B; Delrue L; Bultijnck R; Claeys T; Goetghebeur E; Villeirs G; De Man K; Ameye F; Billiet I; Joniau S; Vanhaverbeke F; De Meerleer G
J Clin Oncol; 2018 Feb; 36(5):446-453. PubMed ID: 29240541
[TBL] [Abstract][Full Text] [Related]
2. The Clinical Efficacy of Radium-223 for Bone Metastasis in Patients with Castration-Resistant Prostate Cancer: An Italian Clinical Experience.
De Luca R; Costa RP; Tripoli V; Murabito A; Cicero G
Oncology; 2018; 94(3):161-166. PubMed ID: 29241166
[TBL] [Abstract][Full Text] [Related]
3. Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): 10-year results from a randomised, phase 3, factorial trial.
Denham JW; Joseph D; Lamb DS; Spry NA; Duchesne G; Matthews J; Atkinson C; Tai KH; Christie D; Kenny L; Turner S; Gogna NK; Diamond T; Delahunt B; Oldmeadow C; Attia J; Steigler A
Lancet Oncol; 2019 Feb; 20(2):267-281. PubMed ID: 30579763
[TBL] [Abstract][Full Text] [Related]
4. Low-dose ruxolitinib plus steroid in severe SARS-CoV-2 pneumonia.
D'Alessio A; Del Poggio P; Bracchi F; Cesana G; Sertori N; Di Mauro D; Fargnoli A; Motta M; Giussani C; Moro P; Vitale G; Giacomini M; Borra G
Leukemia; 2021 Feb; 35(2):635-638. PubMed ID: 33173161
[No Abstract] [Full Text] [Related]
5. Colchicine in Patients with Chronic Coronary Disease.
Nidorf SM; Fiolet ATL; Mosterd A; Eikelboom JW; Schut A; Opstal TSJ; The SHK; Xu XF; Ireland MA; Lenderink T; Latchem D; Hoogslag P; Jerzewski A; Nierop P; Whelan A; Hendriks R; Swart H; Schaap J; Kuijper AFM; van Hessen MWJ; Saklani P; Tan I; Thompson AG; Morton A; Judkins C; Bax WA; Dirksen M; Alings M; Hankey GJ; Budgeon CA; Tijssen JGP; Cornel JH; Thompson PL;
N Engl J Med; 2020 Nov; 383(19):1838-1847. PubMed ID: 32865380
[TBL] [Abstract][Full Text] [Related]
6. Triple Puncture for Primary Trigeminal Neuralgia: A Randomized Clinical Trial.
Zhang YP; Wang Y; Xia WG; Song AQ
Curr Med Sci; 2019 Aug; 39(4):638-644. PubMed ID: 31347002
[TBL] [Abstract][Full Text] [Related]
7. Pretrial Quality Assurance for Hypofractionated Salvage Radiation Therapy After Prostatectomy in the Multi-Institutional PERYTON-trial.
Staal FHE; Siang KNW; Brouwer CL; Janssen J; Budiharto TCG; Haverkort DMAD; Hollmann B; Jacobs I; De Jong MAA; van de Sande MAE; Vanneste BGL; De Jong IJ; Verzijlbergen JF; Langendijk JA; Smeenk RJ; Aluwini S
Adv Radiat Oncol; 2024 Feb; 9(2):101379. PubMed ID: 38405312
[TBL] [Abstract][Full Text] [Related]
8. Improving Communication of Peer-Review Conference Outcomes: A Practical Experience.
Jones JA; Soike MH; Boggs DH; Fiveash JB; Cardan RA; Bonner JA; McDonald AM
Adv Radiat Oncol; 2023; 8(4):101218. PubMed ID: 37124317
[TBL] [Abstract][Full Text] [Related]
9. Implementation of Machine Learning Models to Ensure Radiotherapy Quality for Multicenter Clinical Trials: Report from a Phase III Lung Cancer Study.
Geng H; Liao Z; Nguyen QN; Berman AT; Robinson C; Wu A; Nichols RC; Willers H; Mohammed N; Mohindra P; Xiao Y
Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831358
[TBL] [Abstract][Full Text] [Related]
10. Technological advances in radiotherapy for the treatment of localised prostate cancer.
Mangar SA; Huddart RA; Parker CC; Dearnaley DP; Khoo VS; Horwich A
Eur J Cancer; 2005 Apr; 41(6):908-21. PubMed ID: 15808957
[TBL] [Abstract][Full Text] [Related]
11. Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy.
Vargas C; Martinez A; Kestin LL; Yan D; Grills I; Brabbins DS; Lockman DM; Liang J; Gustafson GS; Chen PY; Vicini FA; Wong JW
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1297-308. PubMed ID: 16029785
[TBL] [Abstract][Full Text] [Related]
12. Association between measures of treatment quality and disease progression in prostate cancer radiotherapy: An exploratory analysis from the TROG 03.04 RADAR trial.
Marcello M; Ebert MA; Haworth A; Steigler A; Kennedy A; Bulsara M; Kearvell R; Joseph DJ; Denham JW
J Med Imaging Radiat Oncol; 2018 Apr; 62(2):248-255. PubMed ID: 29222833
[TBL] [Abstract][Full Text] [Related]
13. Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): an open-label, randomised, phase 3 factorial trial.
Denham JW; Joseph D; Lamb DS; Spry NA; Duchesne G; Matthews J; Atkinson C; Tai KH; Christie D; Kenny L; Turner S; Gogna NK; Diamond T; Delahunt B; Oldmeadow C; Attia J; Steigler A
Lancet Oncol; 2014 Sep; 15(10):1076-89. PubMed ID: 25130995
[TBL] [Abstract][Full Text] [Related]
14. Quality improvements in prostate radiotherapy: outcomes and impact of comprehensive quality assurance during the TROG 03.04 'RADAR' trial.
Kearvell R; Haworth A; Ebert MA; Murray J; Hooton B; Richardson S; Joseph DJ; Lamb D; Spry NA; Duchesne G; Denham JW
J Med Imaging Radiat Oncol; 2013 Apr; 57(2):247-57. PubMed ID: 23551788
[TBL] [Abstract][Full Text] [Related]
15. Quality of life in men with locally advanced prostate cancer treated with leuprorelin and radiotherapy with or without zoledronic acid (TROG 03.04 RADAR): secondary endpoints from a randomised phase 3 factorial trial.
Denham JW; Wilcox C; Joseph D; Spry NA; Lamb DS; Tai KH; Matthews J; Atkinson C; Turner S; Christie D; Gogna NK; Kenny L; Duchesne G; Delahunt B; McElduff P
Lancet Oncol; 2012 Dec; 13(12):1260-70. PubMed ID: 23151431
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
